XNYS 17 Jul, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Lawrence Steven Waldman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2026 | 68,027 | 102,882 | - | 0 | Common Stock | |
| Chris Folena | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 7,371 | 13,448 | - | 0 | Common Stock | |
| Cassandra Nicole Curtis | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 7,371 | 432,983 | - | 0 | Common Stock | |
| Lawrence Steven Waldman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 12,285 | 34,855 | - | 0 | Common Stock | |
| Jennifer Anne Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 20,383 | 0 | - | - | Series B-2 Preferred Stock | |
| Megan Reimers Bent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 46,039 | 46,039 | - | - | Common Stock | |
| Jennifer Anne Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 160,259 | 0 | - | - | Series B-1 Preferred Stock | |
| Jennifer Anne Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 58,718 | 0 | - | - | Series A-1 Preferred Stock | |
| Jennifer Anne Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 146,683 | 146,683 | - | - | Common Stock | |
| Jennifer Anne Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 239,360 | 1,788,861 | - | - | Common Stock | |
| Megan Reimers Bent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 52,151 | - | 0 | Common Stock | |
| Megan Reimers Bent | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 29,546 | 0 | - | - | Series C-2 Preferred Stock | |
| Megan Reimers Bent | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 16,493 | 0 | - | - | Series C-1 Preferred Stock | |
| Lawrence S. Peiros | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 24,142 | 0 | - | - | Series D Preferred Stock | |
| Jared Noah Jacobs | Director | 09 Feb 2026 | 817,340 | 0 | - | - | Series D Preferred Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 874,954 | 0 | - | - | Series C-1 Preferred Stock | ||
| Jared Noah Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 6,112 | - | 0 | Common Stock | |
| Jared Noah Jacobs | Director | 09 Feb 2026 | 7,411,502 | 7,411,502 | - | - | Common Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 107,749 | 0 | - | - | Series A-2 Preferred Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 107,749 | 646,478 | - | - | Common Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 2,274,219 | 2,274,219 | - | - | Common Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 2,274,219 | 0 | - | - | Series D Preferred Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 4,804,965 | 0 | - | - | Series B-1 Preferred Stock | ||
| Jared Noah Jacobs | Director | 09 Feb 2026 | 914,243 | 0 | - | - | Series B-2 Preferred Stock | ||
| Jennifer Anne Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 95,632 | 0 | - | - | Series C-1 Preferred Stock | |
| Lawrence S. Peiros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 69,505 | - | 0 | Common Stock | |
| Lawrence S. Peiros | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 81,514 | 81,514 | - | - | Common Stock | |
| Lawrence S. Peiros | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 57,372 | 0 | - | - | Series C-1 Preferred Stock | |
| Walter Robb | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 16,082 | 0 | - | - | Series B-1 Preferred Stock | |
| Walter Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 134,303 | 134,303 | - | - | Common Stock | |
| Walter Robb | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 Feb 2026 | 5,555 | 145,970 | - | 18 | 99,990 | Common Stock |
| Walter Robb | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 10,210 | 0 | - | - | Series D Preferred Stock | |
| Walter Robb | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 6,657 | 0 | - | - | Series C-1 Preferred Stock | |
| Walter Robb | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 101,354 | 0 | - | - | Series B-2 Preferred Stock | |
| Walter Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 140,415 | - | 0 | Common Stock | |
| Dara Bazzano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 6,112 | - | 0 | Common Stock | |
| Brett J. Thomas | Director | 09 Feb 2026 | 7,411,502 | 7,411,502 | - | - | Common Stock | ||
| Jennifer Anne Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 51,051 | 0 | - | - | Series D Preferred Stock | |
| Brett J. Thomas | Director | 09 Feb 2026 | 817,340 | 0 | - | - | Series D Preferred Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 874,954 | 0 | - | - | Series C-1 Preferred Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 914,243 | 0 | - | - | Series B-2 Preferred Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 4,804,965 | 0 | - | - | Series B-1 Preferred Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 2,274,219 | 0 | - | - | Series D Preferred Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 107,749 | 646,478 | - | - | Common Stock | ||
| Brett J. Thomas | Director | 09 Feb 2026 | 2,274,219 | 2,274,219 | - | - | Common Stock | ||
| Brett J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 6,112 | 6,112 | - | 0 | Common Stock | |
| Brett J. Thomas | Director | 09 Feb 2026 | 107,749 | 0 | - | - | Series A-2 Preferred Stock | ||
| Lawrence Steven Waldman | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 93,500 | 0 | - | - | Stock Appreciation Rights | |
| Chris Folena | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 8,601 | 8,601 | - | - | Employee Stock Options (right to buy) | |
| Chris Folena | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 6,077 | 6,077 | - | 0 | Common Stock | |
| Chris Folena | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 37,400 | 0 | - | - | Stock Appreciation Rights | |
| Cassandra Nicole Curtis | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 8,601 | 8,601 | - | - | Employee Stock Options (right to buy) | |
| Cassandra Nicole Curtis | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 6,077 | 425,612 | - | 0 | Common Stock | |
| Cassandra Nicole Curtis | Director, Chief Innovation Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 37,400 | 0 | - | - | Stock Appreciation Rights | |
| Lawrence Steven Waldman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 31,944 | 31,944 | - | - | Employee Stock Options (right to buy) | |
| Lawrence Steven Waldman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 22,570 | 22,570 | - | 0 | Common Stock | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 133,294 | 0 | - | - | Series A-2 Preferred Stock | |
| John M. Foraker | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 69,445 | 669,933 | - | - | Common Stock | |
| John M. Foraker | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 473,092 | 1,359,846 | - | - | Common Stock | |
| John M. Foraker | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 98,288 | 98,288 | - | - | Employee Stock Options (right to buy) | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 24,179 | 0 | - | - | Series D Preferred Stock | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 57,372 | 0 | - | - | Series C-1 Preferred Stock | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 103,037 | 0 | - | - | Series B-2 Preferred Stock | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 96,118 | 0 | - | - | Series B-1 Preferred Stock | |
| John M. Foraker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Feb 2026 | 59,092 | 0 | - | - | Series A-1 Preferred Stock |